<DOC>
	<DOCNO>NCT02220023</DOCNO>
	<brief_summary>The purpose study measure RV ejection fraction ( RVEF ) , pulmonary flow , pulmonary perfusion exposure inhale nitric oxide patient pulmonary arterial hypertension ( PAH ) know vasodilator-responsive base invasive catheterization well healthy subject . Measurements also make high flow oxygen alone test relative vasodilatory effect oxygen NO . The investigator hypothesize inhaled nitric oxide cardiac MRI use measure dynamic change RV-pulmonary vascular function patient vasodilator-responsive PAH .</brief_summary>
	<brief_title>Dynamic Assessment Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Patients age 18 old Vanderbilt Center Pulmonary Vascular Disease . Vasodilatorresponsive patient identify base prior response inhale nitric oxide invasive right heart catheterization Healthy subject age 18 old know cardiopulmonary disease Standard conventional contraindication cardiac magnetic resonance ( CMR ) image Allergy contraindication Magnevist ( gadopentetate dimeglumine ) contrast Concurrent intravenous epoprostenol infusion performance CMR cumbersome Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>